Loomis, Sayles & Company
OPCH icon

Loomis, Sayles & Company’s Option Care Health OPCH Stock Holding History

Loomis, Sayles & Company’s Portfolio OPCH Stock Details OPCH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$31.8M Buy
1,518,065
+280,318
+23% +$6.52M 0.04% 176
2026
Q1 		$33.3M Sell
1,237,747
-9,676
-0.8% -$314K 0.04% 150
2025
Q4 		$39.7M Buy
1,247,423
+36,546
+3% +$1.07M 0.05% 136
2025
Q3 		$33.6M Buy
1,210,877
+241,581
+25% +$7M 0.04% 159
2025
Q2 		$31.5M Buy
969,296
+30,829
+3% +$996K 0.04% 165
2025
Q1 		$32.8M Sell
938,467
-112,082
-11% -$3.52M 0.05% 156
2024
Q4 		$24.4M Buy
1,050,549
+28,790
+3% +$728K 0.03% 224
2024
Q3 		$32M Sell
1,021,759
-1,424,795
-58% -$43.7M 0.04% 187
2024
Q2 		$67.8M Sell
2,446,554
-233,645
-9% -$6.96M 0.09% 86
2024
Q1 		$89.9M Sell
2,680,199
-15,296
-0.6% -$495K 0.13% 69
2023
Q4 		$90.8M Sell
2,695,495
-354,046
-12% -$10.9M 0.14% 69
2023
Q3 		$98.7M Sell
3,049,541
-106,195
-3% -$3.58M 0.17% 65
2023
Q2 		$103M Buy
3,155,736
+147,956
+5% +$4.46M 0.17% 64
2023
Q1 		$95.6M Buy
3,007,780
+72,790
+2% +$2.18M 0.17% 66
2022
Q4 		$88.3M Buy
2,934,990
+74,244
+3% +$2.3M 0.18% 69
2022
Q3 		$90M Buy
2,860,746
+202,744
+8% +$6.49M 0.18% 68
2022
Q2 		$73.9M Sell
2,658,002
-18,473
-0.7% -$526K 0.14% 77
2022
Q1 		$76.4M Buy
2,676,475
+1,055,722
+65% +$26.5M 0.1% 83
2021
Q4 		$46.1M Buy
1,620,753
+379,090
+31% +$9.95M 0.06% 165
2021
Q3 		$30.1M Buy
+1,241,663
New +$28.8M 0.04% 250
2015
Q3 		– Sell
-162,351
Closed -$2.36M – 1053
2015
Q2 		$2.36M Sell
162,351
-198,074
-55% -$3.35M 0.01% 545
2015
Q1 		$6.39M Sell
360,425
-13,866
-4% -$303K 0.02% 523
2014
Q4 		$10.5M Sell
374,291
-6,844
-2% -$170K 0.03% 497
2014
Q3 		$10.5M Buy
381,135
+37,288
+11% +$1.16M 0.03% 482
2014
Q2 		$11.5M Buy
343,847
+50,707
+17% +$1.52M 0.03% 484
2014
Q1 		$8.18M Buy
+293,140
New +$9.05M 0.02% 515
2013
Q3 		– Sell
-257,053
Closed -$17M – 762
2013
Q2 		$17M Buy
+257,053
New +$14.4M 0.06% 353

Other funds holding OPCH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DCP
Durable Capital Partners Bethesda, Maryland $10.3B AUM 29.04% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Loomis, Sayles & Company's OPCH Position: Q2 2026 in Review

Loomis, Sayles & Company increased its Option Care Health (OPCH) stake by 23% in Q2 2026, buying an estimated $6.52M and bringing the position to 1,518,065 shares worth $31.8M. The position accounts for 0.04% of the portfolio, ranked #176.

Loomis, Sayles & Company first reported a position in OPCH in Q2 2013 and has held it in 27 quarters since. The position peaked at $103M in Q2 2023. 371 funds tracked by Wall St. Rank hold OPCH as of Q2 2026.

  • Loomis, Sayles & Company held 1,518,065 shares of Option Care Health worth $31.8M as of Q2 2026.
  • Loomis, Sayles & Company bought 280,318 Option Care Health shares in Q2 2026, an estimated $6.52M.
  • Option Care Health made up 0.04% of Loomis, Sayles & Company's portfolio in Q2 2026, its #176 holding.
  • Loomis, Sayles & Company first reported a position in Option Care Health in Q2 2013 and has held it in 27 quarters since.
  • Loomis, Sayles & Company's Option Care Health position peaked at $103M in Q2 2023.
  • 371 funds tracked by Wall St. Rank held Option Care Health as of Q2 2026.

Based on Loomis, Sayles & Company's 13F filing for Q2 2026, filed 14 Aug 2026.